Benitec生物製藥 BNTC 深 滬
等待開盤 08-07 09:30:00 美东时间
11.65
+0.125
+1.08%
華盛通- 最 高11.655
- 今 開11.57
- 成交量 3.14万股
- 最 低 11.35
- 昨 收 11.525
- 總市值 3.06亿
- 52周最高 17.15
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 8.06
- 委 比 -87.18%
- 總股本 2625.05万
- 歷史最高 5609.5744
- 量 比 0.55
- 振 幅 2.65%
- 歷史最低 2.227
- 每 手 1
- 風險率 2.08%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Benitec Biopharma Advances BB-301 Clinical Study
Benitec Biopharma ( ($BNTC) ) has provided an update. On July 9, 2025, Benitec ...
07-10 04:51
Benitec Biopharma Receives Green Light To Advance BB-301 Trial After Safety Review; Cohort 2 Enrollment Set For Q4 2025
-In April 2025 the Sixth and Final Subject of Cohort 1 was Safely Treated with the Low Dose of BB-301 in the Phase 1b/2a Clinical Treatment Study (NCT06185673)--Independent Data Safety Monitoring Board Review Has Been
07-09 20:18
Benitec Biopharma Provides Operational Updates
An independent Data Safety Monitoring Board has recommended continuing enrollment in Benitec Biopharma's Phase 1b/2a clinical study for BB-301 after reviewing safety data from Cohort 1, with Cohort 2 enrollment expected to begin in Q4 2025.
07-09 12:00
美股大行评级 | 摩根大通：维持网易"超配"评级，目标价升至135美元；瑞银上调达美航空评级至"买入"
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1131517965561573377.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Armata Pharmaceuticals(ARMP)"买入"评级，目标价从7美元升至9美元</p> <p>• 瑞银：维持爱芬奇(ANF)"买入"评级，目标价从115美
05-20 09:28
美股大行评级 | 潜在涨幅1281.22%！Cabaletta Bio获Guggenheim升目标价至25美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1130057143861719040.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim：维持Cabaletta Bio(CABA)"买入"评级，目标价从23美元升至25美元</p> <p>• 瑞穗：维持Tectonic Therapeutic(TECX)"跑赢大市"评级，目标价从51美元
05-16 08:43
JMP Securities Reiterates Market Outperform on Benitec Biopharma, Maintains $20 Price Target
JMP Securities analyst Silvan Tuerkcan reiterates Benitec Biopharma (NASDAQ:BNTC) with a Market Outperform and maintains $20 price target.
05-15 21:45
Benitec Biopharma Q3 EPS $(0.24) Beats $(0.35) Estimate
Benitec Biopharma (NASDAQ:BNTC) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.35) by 31.43 percent. This is a 85.37 percent increase over losses of $(1.64) per share from
05-14 20:13
美股机会日报丨继续反制！中国对美所有商品加征125%关税；热门中概股走高
继续反制！中国对美所有商品加征125%关税；美国3月PPI同比增长2.7%，不及预期；热门中概股走高，小鹏汽车涨超8%，哔哩哔哩涨超5%；美股黄金股盘前上涨，科尔黛伦矿业、金田涨超4%>>
04-11 20:37
美股大行评级 | 潜在涨幅506%！ JMP首予MBX Biosciences"跑赢大市"评级，目标价38美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1117373634651086848.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Canaccord Genuity：维持Travere Therapeutics(TVTX)"买入"评级，目标价从45美元升至47美元</p> <p>• JMP证券：维持Benitec生物制药(BNTC)"跑赢大市"评级，
04-11 09:36
Benitec Biopharma prices $30M securities offerings
Benitec Biopharma (NASDAQ:BNTC) is looking to raise around $30M in gross proceeds via its securities offerings. The biotechnology company is selling 1,443,000 shares of its common stock (or pre-funded...
03-25 20:50
